Healthcare Triangle, Inc. (HCTI)
HCTI Chart as of 2025-03-12
Stock Information
| CEO: | – |
| CFO: | – |
| Employees: | 22 |
| Address: | 7901 Stoneridge Drive, Pleasanton, CA, United States |
| Country: | United States |
| Website: | https://www.healthcaretriangle.com |
| Listing Date: | – |
| Founded: | – |
| Founder: | – |
| Current Price: | 0.505 USD |
| Today Change: | 55.38% |
| Outstanding Shares: | 6,401,820 |
| Volume: | 13,151,302 |
| Avg Volume: | 3,309,701 |
| Expert Target Price: | – (Institutions: 0) |
| EPS: | – |
| PER: | – |
| Dividend Date: | – |
| Last Split Date: | 2023-05-26 |
| Last Split Factor: | 1:10 |
Key Executives
| Name | Title | Pay | Year |
|---|---|---|---|
| Mr. Thyagarajan Ramachandran | Chief Financial Officer | 267.5k | — |
| Mr. Shibu Kizhakevilayil | Head of M&A and Director | 229.88k | — |
| Mr. Chris Paalman | Director of Engineering & Operations | — | — |
Financials
Income Statement
| Metric | Amount |
|---|---|
| Total Revenue | 33,203,000 |
| Cost Of Revenue | 26,426,000 |
| Gross Profit | 6,777,000 |
| Operating Income | -11,348,000 |
| Net Income | -12,339,000 |
Balance Sheet
| Metric | Amount |
|---|---|
| Total Assets | 10,049,000 |
| Total Liabilities | – |
| Total Stockholder Equity | – |
Cash Flow
| Metric | Amount |
|---|---|
| Total Cash From Operating Activities | – |
| Capital Expenditures | – |
SEC Filings (Gemini Summaries)
| AccNo | Date | Summary |
|---|---|---|
| 0002059578-25-000001 | 2025-03-07 | The filing defines CSS styles for text boxes and tables. It specifies borders, padding, fonts, colors, text alignment, and wrapping behavior for various table elements. |
| 0001213900-25-021346 | 2025-03-07 | Healthcare Triangle’s definitive proxy statement details the 2024 annual meeting (virtual, March 28, 2025). Stockholders will vote on director elections, an amendment to the 2020 Stock Incentive Plan, and the ratification of M&K CPAS, PLLC as auditor. Board recommends voting FOR all proposals. |
| 0001213900-25-020571 | 2025-03-05 | Healthcare Triangle files a preliminary info statement regarding approved corporate actions: a reverse stock split (1:2-1:250), increased authorized shares (110M to 1.01B), and warrant issuance approval. Majority stockholders approved these actions; no proxy is required. |
| 0001213900-25-018926 | 2025-03-03 | Healthcare Triangle (HCTI) filed an 8-K on 2/27/25 re: a private placement. They sold 36.2M units @ $0.42 to institutional investors. Each unit includes common stock or a pre-funded warrant, Series A & B warrants. Warrants are exercisable after stockholder approval and contain a one-time price reset. |
| 0001213900-25-017578 | 2025-02-27 | Healthcare Triangle (HCTI) filed an 8-K on 2/26/25, reporting Nasdaq notice of non-compliance with minimum $1.00 share price (Rule 5550(a)(2)). HCTI has until 8/25/25 to regain compliance. They also address a previous delisting notice for not meeting stockholders equity requirements. |
News Summary
– Spartan Capital Securities, LLC Announces Key February Transactions
2025-03-07 21:56:00 | GlobeNewswire
New York, NY, March 07, 2025 (GLOBE NEWSWIRE) — Spartan Capital Securities, LLC, a full-service investment banking firm, is pleased to announce a series of strategic transactions completed in February 2025, reinforcing its position as a trusted financial par…
Link
Analysis of Today’s Move
**Blog Analysis: Healthcare Triangle (HCTI) Stock Rally Explained**
Healthcare Triangle (HCTI) experienced a noticeable stock rally today. This rise appears counterintuitive given recent company disclosures. These disclosures highlight significant challenges facing the organization. The rally’s likely cause is multifaceted.
One crucial factor is Spartan Capital Securities’ announcement. Their press release, published today, discusses key February transactions. While the release does not specifically mention HCTI, market speculation may link these transactions. Investors could be anticipating positive impacts on HCTI.
However, recent SEC filings paint a concerning picture. The company received a Nasdaq non-compliance notice. This notice stems from failing to maintain a minimum $1.00 share price. They have until August 2025 to regain compliance.
Furthermore, a preliminary information statement details significant corporate actions. These actions include a proposed reverse stock split. Also proposed is a substantial increase in authorized shares. Majority stockholders have already approved these actions.
Moreover, a recent 8-K revealed a private placement offering. Healthcare Triangle sold units to institutional investors. Each unit included common stock (or pre-funded warrants) and Series A & B warrants. The warrants contain a one-time price reset feature.
In conclusion, the stock rally seems disconnected from fundamental realities. While Spartan Capital’s announcement may offer some hope, serious challenges remain. Investors should proceed with caution. Thoroughly evaluate all available information before investing.
This stock has shown a change of 55.38% today.
Please consider that all investment decisions carry risk;
none of the content here should be construed as financial advice.
Always do your own research or consult a professional before making investment decisions.
The information provided in this article is for informational purposes only
and does not constitute legal, tax, or investment advice.
Investing involves risk, including the potential loss of principal.
Leave a Reply